Linderalactone
CAS No. 728-61-0
Linderalactone ( Linderalactone )
产品货号. M19045 CAS No. 728-61-0
乌药内酯对人中性粒细胞响应 fMLP/CB 产生超氧阴离子显示出显着的抑制作用,IC5 值为 8.48 μg/mL。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥648 | 有现货 |
|
10MG | ¥1037 | 有现货 |
|
25MG | ¥1774 | 有现货 |
|
50MG | ¥2641 | 有现货 |
|
100MG | ¥3937 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Linderalactone
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述乌药内酯对人中性粒细胞响应 fMLP/CB 产生超氧阴离子显示出显着的抑制作用,IC5 值为 8.48 μg/mL。
-
产品描述Linderalactone is an NSAID isolated from Lindera aggregata.
-
体外实验Cell Viability Assay Cell Line:Lung cancer A549 cells Concentration:0 μM, 1.6 μM, 3.2 μM, 6.25 μM, 12.5 μM, 25 μM, 50 μM, 100 μM Incubation Time:24 hours Result:Inhibited the growth of A549 cells concentration-dependently.Apoptosis Analysis Cell Line:Lung cancer A549 cells Concentration:7.5 μM, 15 μM, 30 μM Incubation Time:Result:Induced apoptosis in A549 cells in a dose-dependent manner. Cell Cycle Analysis Cell Line:Lung cancer A549 cells Concentration:7.5 μM, 15 μM, 30 μM Incubation Time:24 hours Result:Induced G2/M cell cycle arrest.Western Blot Analysis Cell Line:Lung cancer A549 cells Concentration:7.5 μM, 15 μM, 30 μM Incubation Time:Result:Inhibited the JAK/STAT pathway in A549 cells.
-
体内实验——
-
同义词Linderalactone
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number728-61-0
-
分子量244.29
-
分子式C15H16O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 33.33 mg/mL (136.44 mM)
-
SMILESCC1=CCCC2=CC(C3=C(C1)OC=C3C)OC2=O
-
化学全称(R,7Z,10E)-3,11-dimethyl-4,8,9,12-tetrahydro-6H-4,7-(metheno)furo[3,2-c][1]oxacycloundecin-6-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
9-Methoxycanthin-6-o...
9-Methoxycanthin-6-one 具有抗肿瘤活性,对 KB、LU-1、LNCaP、HL-60 癌细胞和其他人类癌细胞系具有细胞毒活性,IC50 值约为 1-4 μg/mL。
-
4-Nitrocinnamic acid
4-Nitrocinnamic acid is a photosensitive compound. 4-Nitrocinnamic acid has inhibitory effects on tyrosinase.
-
Clindamycin
克林霉素通过作用于 50S 核糖体来抑制蛋白质合成。